Replies to post #5703 on Cytogenix (fka CYGX)

[peace_2_all]

neo43, I agree that is the route they are taking. Let us just hope the markets will stay perky and keep pumping liquidity into the economy. This will in turn open up the pockets of lenders favorably for CYGX. It is a good plan if the markets don't turn south, imo.

[specul8]

The risk here is that the company miscalculates on their ability to get there stock higher before the possibility of an exogenous factor negatively impacts liquidity in the market, and money flows to the biotech sector. The ole "bird in the hand" concept usually proves to be the right option. Stating you have cash on hand for three or so months does not leave one with a cozy feeling...I believe managemnt must seek out and capture at least two years worth of capital to put these types of concerns to rest. Market reaction would be quite favorable, despite the dilution. We are talking about huge revenues if our products reach commercialization. There would be no excuse if management missed the current opportunity in this favorable capital raising environment...I have to assume the company has some major announcements anticipated over the next 30-60 days. As I said before, if this company was still private, I would bet an investment banker would sign on to begin the process of taking this company public at between $5 and $10 per share. Certainly there must be interest in funding this company at current PPS levels.